Cargando…

Disruption of YY1-EZH2 Interaction Using Synthetic Peptides Inhibits Breast Cancer Development

SIMPLE SUMMARY: Both Yin Yang 1 (YY1) and enhancer of zeste homolog 2 (EZH2) are oncogenes with overexpressed statuses in cancers. As a transcription factor, YY1 recruits EZH2 through its oncoprotein binding (OPB) domain to repress gene expression. In this study, we identified the interaction domain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Cheng, Li, Guangyue, Wang, Wenmeng, Sun, Yixuan, Zhang, Yueling, Zhong, Chen, Stovall, Daniel B., Li, Dangdang, Shi, Jinming, Sui, Guangchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156467/ https://www.ncbi.nlm.nih.gov/pubmed/34065631 http://dx.doi.org/10.3390/cancers13102402

Ejemplares similares

A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters
por: Wang, Wenmeng, et al.
Publicado: (2022)

YY1 Oligomerization Is Regulated by Its OPB Domain and Competes with Its Regulation of Oncoproteins
por: Qiao, Shiyao, et al.
Publicado: (2022)

Advances of Zinc Signaling Studies in Prostate Cancer
por: Li, Dangdang, et al.
Publicado: (2020)

Integrative genomic analyses of promoter G-quadruplexes reveal their selective constraint and association with gene activation
por: Li, Guangyue, et al.
Publicado: (2023)

Phase-Separated Subcellular Compartmentation and Related Human Diseases
por: Zhang, Lin, et al.
Publicado: (2022)

Polydatin Inhibits Hepatocellular Carcinoma Cell Proliferation and Sensitizes Doxorubicin and Cisplatin through Targeting Cell Mitotic Machinery
por: Farooq, Umar, et al.
Publicado: (2023)

Thymoquinone Selectively Induces Hepatocellular Carcinoma Cell Apoptosis in Synergism With Clinical Therapeutics and Dependence of p53 Status
por: Jehan, Shah, et al.
Publicado: (2020)

Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network
por: Hao, Aixin, et al.
Publicado: (2021)

Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression
por: Wang, Jinhua, et al.
Publicado: (2022)

SOX7 Target Genes and Their Contribution to Its Tumor Suppressive Function
por: Zhang, Yumeng, et al.
Publicado: (2018)

Quercetin Induces Apoptosis in HepG2 Cells via Directly Interacting with YY1 to Disrupt YY1-p53 Interaction
por: Guan, Hui, et al.
Publicado: (2023)

Mechanisms regulating DMTF1β/γ expression and their functional interplay with DMTF1α
por: Li, Jialiang, et al.
Publicado: (2020)

Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013)

The anorexic hormone Peptide YY(3–36) is rapidly metabolized to inactive Peptide YY(3–34) in vivo
por: Toräng, Signe, et al.
Publicado: (2015)

Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer
por: Chen, Huiming, et al.
Publicado: (2015)

The role of peptide YY in gastrointestinal diseases and disorders
por: EL-SALHY, MAGDY, et al.
Publicado: (2013)

Pharmacological inhibition of EZH2 disrupts the female germline epigenome
por: Prokopuk, Lexie, et al.
Publicado: (2018)

Tet inactivation disrupts YY1 binding and long-range chromatin interactions during embryonic heart development
por: Fang, Shaohai, et al.
Publicado: (2019)

Multiple roles of Ring 1 and YY1 binding protein in physiology and disease
por: Zhan, Shaohua, et al.
Publicado: (2018)

Knockdown of TRIM44 inhibits the progression of ovarian cancer and is related to the FOXM1-EZH2 signaling pathway
por: Meng, Fanling, et al.
Publicado: (2022)

Homeostasis Imbalance of YY2 and YY1 Promotes Tumor Growth by Manipulating Ferroptosis
por: Li, Yanjun, et al.
Publicado: (2022)

Genome-wide analysis of YY2 versus YY1 target genes
por: Chen, Li, et al.
Publicado: (2010)

Function of YY1 in Long-Distance DNA Interactions
por: Atchison, Michael L.
Publicado: (2014)

Cholinergic Regulation of Ghrelin and Peptide YY Release May Be Impaired in Obesity
por: Maier, Christina, et al.
Publicado: (2008)

Plasma and tissue alterations of peptide YY and enteroglucagon in rats after colectomy.
por: Vukasin, A. P., et al.
Publicado: (1992)

Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut–brain axis
por: Holzer, Peter, et al.
Publicado: (2012)

Peptide YY and neuropeptide Y in regulation of pain and spatial learning and memory
por: Jain, Piyush, et al.
Publicado: (2012)

A Short-Length Peptide YY Analogue with Anorectic Effect in Mice
por: Nishizawa, Naoki, et al.
Publicado: (2017)

Effects of Peptide YY on the Hypothalamic-Pituitary-Gonadal Axis in Healthy Men
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2019)

Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
por: Ratz, Leonie, et al.
Publicado: (2022)

Disruption of FOXP3–EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation
por: Bamidele, Adebowale O., et al.
Publicado: (2018)

Diet and Gastrointestinal Bypass–Induced Weight Loss: The Roles of Ghrelin and Peptide YY
por: Chandarana, Keval, et al.
Publicado: (2011)

Visceral hyperalgesia caused by peptide YY deletion and Y2 receptor antagonism
por: Hassan, Ahmed M., et al.
Publicado: (2017)

Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction
por: Haj-Yehia, Elias, et al.
Publicado: (2020)

Synthetic Mimic of Antimicrobial Peptide with Nonmembrane-Disrupting Antibacterial Properties
por: Gabriel, Gregory J., et al.
Publicado: (2008)

Retroposition and evolution of the DNA-binding motifs of YY1, YY2 and REX1
por: Kim, Jeong Do, et al.
Publicado: (2007)

HTLV-1 Tax disrupts the host epigenome by interacting with a Polycomb group protein EZH2
por: Fujikawa, Dai, et al.
Publicado: (2014)

YY1 Interacts with Guanine Quadruplexes to Regulate DNA Looping and Gene Expression
por: Li, Lin, et al.
Publicado: (2020)

The Roles of Neuropeptide Y (Npy) and Peptide YY (Pyy) in Teleost Food Intake: A Mini Review
por: Assan, Daniel, et al.
Publicado: (2021)

From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform
por: Tian, Na, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8errseu2tne17ffv8sdqhuui8i